Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Interspace, First Half Ordinary Profit Decreases by 34%, Jan-Mar Ordinary Profit Decreases by 59%
2122 Interspace Co.,Ltd. 【J-GAAP】
Earnings ReportInterspace Co.,Ltd. <2122> [TSE Std] announced its financial results after the market closed on May 13th (15:30). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending September 2025 (October 2024 to March 2025) dropped 34.1% from the same period last year to 280 million yen. The progress rate toward the full-year plan of 750 million yen was 37.3%, also falling below the five-year average of 60.2%.
Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the April to September period (2H) is expected to surge 7.2 times that of the same period last year, reaching 470 million yen.
In the most recent three-month period, from January to March (2Q), the consolidated ordinary profit significantly dropped to 125 million yen, a 58.6% decrease compared to the same period last year. The operating profit margin significantly dropped from 13.8% in the same period last year to 7.8%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2022 | 3,776 | 566 | 615 | 413 | 65.9 | 67.7 | May 9, 2023 | J-GAAP |
| Oct - Mar, 2023 | 3,996 | 435 | 425 | 250 | 40.0 | 86.7 | May 14, 2024 | J-GAAP |
| Oct - Mar, 2024 | 4,466 | 292 | 280 | 134 | 21.5 | 37.3 | May 13, 2025 | J-GAAP |
| YoY | +11.8% | -32.9% | -34.1% | -46.4% | -46.2% |
First Half Results vs. Previous Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Oct - Mar, 2024 Guidance | 4,300 | 300 | 300 | 150 | 23.9 | 0 | Nov 12, 2024 | J-GAAP |
| Oct - Mar, 2024 Results | 4,466 | 292 | 280 | 134 | 21.5 | 0 | May 13, 2025 | J-GAAP |
| Revision Rate | +3.9% | -2.7% | -6.7% | -10.7% | -10.1% |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Apr - Sep, 2024 | 3,913 | 120 | 65 | -191 | -30.7 | 30 | Nov 12, 2024 | J-GAAP |
| Apr - Sep, 2025 Guidance | 4,534 | 458 | 470 | 266 | 42.4 | 30 | May 13, 2025 | J-GAAP |
| YoY | +15.9% | +281.7% | +623.1% | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Sep, 2023 | 7,284 | 791 | 908 | 585 | 93.4 | 25 | Nov 14, 2023 | J-GAAP |
| Sep, 2024 | 7,909 | 555 | 490 | 59 | 9.5 | 30 | Nov 12, 2024 | J-GAAP |
| Sep, 2025 Guidance | 9,000 | 750 | 750 | 400 | 63.7 | 30 | Nov 12, 2024 | J-GAAP |
| YoY | +13.8% | +35.1% | +53.1% | +578.0% | +572.3% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Mar, 2024 | 2,163 | 299 | 302 | 182 | 29.1 | 13.8 | May 14, 2024 | J-GAAP |
| Apr - Jun, 2024 | 1,944 | 89 | 91 | 25 | 4.0 | 4.6 | Aug 13, 2024 | J-GAAP |
| Jul - Sep, 2024 | 1,969 | 31 | -26 | -216 | -34.7 | 1.6 | Nov 12, 2024 | J-GAAP |
| Oct - Dec, 2024 | 2,076 | 105 | 155 | 90 | 14.4 | 5.1 | Feb 12, 2025 | J-GAAP |
| Jan - Mar, 2025 | 2,390 | 187 | 125 | 44 | 7.1 | 7.8 | May 13, 2025 | J-GAAP |
| YoY | +10.5% | -37.5% | -58.6% | -75.8% | -75.7% |
Related Articles
Nitori, 5% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 2 yen
SANTEN PHARMA, 6% Decrease in Net Income for The Current Fiscal Year, Dividend Raised by 2 yen
StemCell Institute, 5% Increase in Ordinary Profit, Update Record High for Third Consecutive Term
SHIP HEALTHCARE, 2% Increase in Ordinary Profit, Update Record High for Third Consecutive Term, Dividend Raised by 2 yen
robot home, Jan-Mar (1Q) Ordinary Profit Decreases by 71%
Shikino High-Tech, 2.4 times Increase in Ordinary Profit for The Current Fiscal Year
Will Smart, Jan-Mar (1Q) Ordinary Profit loss of 54 Million Yen
MIRAIT ONE, 24% Increase in Ordinary Profit for The Current Fiscal Year, Dividend Raised by 10 yen
MEDINET, First Half Ordinary Profit Loss Widens, Jan-Mar Ordinary Profit Loss Widens
ZOOM, Jan-Mar (1Q) Ordinary Profit Turns to Loss